TD Cowen analyst Yaron Werber reiterated a Buy rating on Dianthus Therapeutics (NASDAQ: DNTH)The analyst commented, "DNTH confirms Go decision ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments